A Study to Test the Long-term Safety, Tolerability and Efficacy of Brivaracetam in Study Participants 2 to 26 Years of Age With Childhood Absence Epilepsy or Juvenile Absence Epilepsy

NCT05109234 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

84

Enrollment

INDUSTRY

Sponsor class

Conditions

Childhood Absence Epilepsy
Juvenile Absence Epilepsy

Interventions

DRUG: Brivaracetam Film-coated tablet
DRUG: Brivaracetam oral solution

Sponsor

UCB Biopharma SRL